Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Stomach Neoplasm
and you are
between 19 and 74
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study evaluates the survival benefit and safety of cytoreductive surgery(CRS) combined with HIPEC and chemotherapy in gastric cancer with peritoneal metastasis.

Provided treatments

  • Procedure: Cytoreductive surgery
  • Procedure: Hyperthermic Intraperitoneal Chemotherapy
  • Drug: Fluoropyrimidine
  • Drug: Cisplatin
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03023436. The sponsor of the trial is Nanfang Hospital of Southern Medical University and it is looking for 220 volunteers for the current phase.
Official trial title:
Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy and Systemic Chemotherapy in Gastric Cancer With Regional Peritoneal Metastasis, a Multicenter and Single-arm Phase III Study